Xcout Intel
Golgenia competitors & alternatives
The 12 closest competitors and alternatives to Golgenia among biotech companies — ranked by similarity to what Golgenia actually does, not by market-cap band.
Subscribe to see Golgenia’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Golgenia
Golgenia is a research and development company operating in the drug discovery industry and advancing its GSL oncology platform. Headquartered in Milan, Italy, the company closed a 1.5 million euro Series A financing to support its pipeline toward first-in-human trials.
Golgenia at a glance
Golgenia is a biotech company headquartered in Italy. Its most recent funding round, Series A, raised $1.6M in July 2026. Xcout tracks 11 named people at Golgenia, including Khalid Islam, Ph.D. (Chairman and CEO).
Golgenia leadership
- Khalid Islam, Ph.D.Chairman and CEO
- Gianni LuiniChief Operating Officer
- Alberto Luini, M.D.Chief Scientific Officer
- Khalid IslamCEO and co-founder
- Alberto LuiniChief Scientific Officer and co-founder
- Fiorentino Izzoresearch and development
5 more named people on record for Golgenia, with roles, board committees and tenure — see the full roster →
Golgenia funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $1.6M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent Golgenia news
Top 12 Golgenia competitors
Ranked by semantic similarity — how close each company is to Golgenia by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
858 Therapeutics is a biotechnology and drug discovery company headquartered in San Diego, California, which recently raised a $50 million Series B financing.
Biotechnology
Tolemy Bio is an AI-native virtual cell platform company with operations in Cambridge, United Kingdom, and Barcelona, Spain. The company focuses on virtual cell technologies for therapeutic development and manufacturing.
Biotechnology
Pi Therapeutics is an Israeli preclinical-stage pharmaceutical company founded in 2015 and based in Ness Ziona. The company focuses on drug discovery and develops novel modulators of protein degradation for the treatment of cancer.
Biotechnology
Sightera Biosciences is an Antwerp-based biotechnology startup leveraging clinically correlated patient data and an artificial intelligence platform to advance drug discovery and design.
Similar biotech company
Mironid Limited is a privately held drug discovery company founded in 2015 and headquartered in Glasgow, Scotland. The patient-focused company develops innovative therapeutics to improve the treatment of various medical conditions.
Biotechnology
Cumulus Oncology operates Europe's first oncology biotech creation engine, identifying promising therapeutic assets and spinning out specialized companies. Headquartered in Edinburgh, Scotland, the company secured £9m in seed financing to accelerate its oncology drug development model. It employs a lean team dedicated to oncology asset creation.
Biotechnology
LigaChem Biosciences is a clinical-stage biopharmaceutical company headquartered in Daejeon, South Korea. The company specializes in the discovery and development of novel therapeutics utilizing proprietary technology platforms such as antibody-drug conjugates. With decades of dedicated drug development experience, it drives global healthcare innovation through open collaboration.
Biotechnology
Superluminal Medicines is a generative biology and chemistry company headquartered in Boston, Massachusetts, focused on drug discovery and development.
Similar biotech company
Valerio Therapeutics is a biotechnology company that develops precision-guided therapeutics for complex and underserved diseases. It utilizes a proprietary V-Body conjugate platform, based on synthetic single-domain antibody libraries, to enable targeted drug delivery and deep tissue penetration.
Biotechnology
Full-Life Technologies Limited is a fully integrated global radiopharmaceutical company focused on drug development in oncology, headquartered in Shanghai, China, with additional operations in Europe.
Similar biotech company
HitGen Inc. is a biopharmaceutical and contract research company that provides drug discovery services and technologies to the global pharmaceutical and biotechnology industry. It specializes in DNA-encoded library (DEL) technology, fragment-based drug discovery, structure-based drug design, and oligonucleotide-based therapeutics to discover novel small molecules and therapeutics for global clients and internal pipelines.
Similar biotech company
Basecamp Bio Inc. is a California-based drug discovery and development company founded in 2021. The company utilizes a structure-based drug discovery engine to develop new drugs, cell and gene therapies, regenerative medicine, and immunotherapies.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Golgenia and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Golgeniaand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →